000 | 04536nab a22004937a 4500 | ||
---|---|---|---|
999 |
_c9230 _d9230 |
||
005 | 20250625151729.0 | ||
008 | 250512s2025 ||||| |||| 00| 0 eng d | ||
040 | _aAFVC | ||
100 |
_aCagney, Jack _913941 |
||
245 |
_aPrevalence of sexual violence against children and age at first exposure : _ba global analysis by location, age, and sex (1990–2023) _cJack Cagney, Cory Spencer, Luisa Flor, Molly Herbert, Mariam Khalil, Erin O’Connell, Erin Mullany, Flavia Bustreo, Joht Singh Chandan, Nicholas Metheny, Felicia Knaul and Emmanuela Gakidou |
||
260 |
_bElsevier, _c2025 |
||
500 | _aThe Lancet, 2025, First published online, 7 May 2025 | ||
520 | _aBackground Measuring sexual violence against children (SVAC) is vital to prevention and advocacy efforts, yet existing prevalence studies present estimates for few countries. Here we estimate the prevalence of SVAC for 204 countries by age and sex, from 1990 to 2023, and also report the age at which young survivors of lifetime sexual violence first experienced sexual violence. Methods We reviewed publicly available repositories for data on the prevalence of SVAC. To harmonise heterogeneity in the identified input data, we adjusted for alternative case definitions of SVAC and differential disclosure by survey mode. We then used a spatiotemporal Gaussian process regression to estimate a full time series of exposure to SVAC for each age-sex-country combination. We accounted for uncertainty in the underlying data and modelling processes. We also analysed the age at which adolescent and young adult survivors of lifetime sexual violence first experienced this type of violence by sex, data source, and world region. Findings We estimate that the global age-standardised prevalence of SVAC was 18·9% (95% uncertainty interval [UI] 16·0–25·2) for females and 14·8% (9·5–23·5) for males in 2023. At the super-region level, these estimates ranged from 12·2% (9·0–17·2) in southeast Asia, east Asia, and Oceania to 26·8% (21·9–32·7) in south Asia for females and from 12·3% (5·2–24·6) in central Europe, eastern Europe, and central Asia to 18·6% (9·7–32·3) in sub-Saharan Africa for males. At the country level, age-standardised estimates ranged from 6·9% (4·8–9·6) in Montenegro to 42·6% (34·4–52·1) in Solomon Islands among females and from 4·2% (1·7–9·2) in Mongolia to 28·3% (13·2–49·8) in Côte d’Ivoire among males. Globally, these estimates remained relatively stable since 1990, with slight variations at the country and regional levels. We also find that the first experience of sexual violence among adolescents and young people occurred before the age of 18 years for 67·3% of female and 71·9% of male survivors. Interpretation The prevalence of SVAC is extremely high for both females and males across the globe. Given data sparsity and ongoing measurement challenges, findings probably underestimate the true pervasiveness of SVAC. An overwhelmingly high proportion of survivors first experienced sexual violence during childhood, revealing a narrow yet sensitive window that should be targeted in future prevention efforts. It is a moral imperative to protect children from violence and mitigate its compounding impacts on health across the lifecourse. (Authors' abstract). Record #9230 | ||
650 |
_aCHILD SEXUAL ABUSE _9121 |
||
650 |
_aINTERNATIONAL COMPARISON _93394 |
||
650 |
_aPREVALENCE _9457 |
||
650 |
_aRAWEKE TAMARIKI _95562 |
||
650 |
_aSEXUAL VIOLENCE _9531 |
||
650 |
_aTATAURANGA _9598 |
||
651 |
_aINTERNATIONAL _93624 |
||
651 |
_aAFRICA _93364 |
||
651 |
_aASIA _93363 |
||
651 |
_aAUSTRALIA _92597 |
||
651 |
_aEUROPE _93372 |
||
651 |
_aNEW ZEALAND _92588 |
||
651 | _2PACIFIC | ||
651 |
_aNORTH AMERICA _913943 |
||
651 |
_aSOUTH AMERICA _910189 |
||
700 |
_aSpencer, Cory _913944 |
||
700 |
_aFlor, Luisa _913945 |
||
700 |
_aHerbert, Molly _913946 |
||
700 |
_aKhalil, Mariam _913947 |
||
700 |
_aO'Connell, Erin _913948 |
||
700 |
_aMullany, Erin _913949 |
||
700 |
_aBustreo, Flavia _913950 |
||
700 |
_aChandan, John S. _913951 |
||
700 |
_aMetheny, Nicholas _912969 |
||
700 |
_aKnaul, Felicia _912970 |
||
700 |
_aGakidou, Emmanuela _913952 |
||
773 | 0 | _tThe Lancet, 2025, First published online, 7 May 2025 | |
830 |
_aThe Lancet _94435 |
||
856 |
_uhttps://doi.org/10.1016/S0140-6736(25)00311-3 _zdoi:10.1016/S0140-6736(25)00311-3 (Open access) |
||
942 |
_2ddc _cARTICLE _hnews133 |